Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
1.90 Down 0.10(5.00%) Dec 2, 4:00PM EST
Prev Close:2.00
Open:N/A
Bid:N/A
Ask:2.00 x 100
1y Target Est:16.00
Beta:1.82136
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.35 - 9.60
Volume:0
Avg Vol (3m):138,365
Market Cap:4.18M
P/E (ttm):N/A
EPS (ttm):-10.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DCTHDown 5.00%4.18M
ONXXF 0.00%N/A
LLYUp 2.64%71.45B
PFEUp 0.54%191.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.72
Quarterly EPS Est (Dec-16) :-3.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback